RxDoctor Payments Data

David Castellone, MD

Family Medicine · Summerville, SCNPI 1356308654

Payments from drug & device makers

$9,804in general payments, 2019–2025

Across 581 payments — averaging $16.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • GSK$658
  • AstraZeneca$604
  • Novo Nordisk$587
  • Sanofi-aventis U.S. LLC$525
  • Pfizer$505
  • plus $6K from 54 others

What the payments were for

  • Food & beverage$9,804100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)86$1,026
GSK42$658
AstraZeneca34$604
Novo Nordisk40$587
Sanofi-aventis U.S. LLC28$525
Pfizer34$505
Amgen(2 entities)18$333
Esperion Therapeutics, Inc.17$282
Lilly USA, LLC16$276
Abbott13$270
Supernus Pharmaceuticals, Inc.6$258
Johnson & Johnson18$251
Novartis14$242
Otsuka America Pharmaceutical, Inc.11$212
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC13$211
E.r. Squibb & Sons, L.L.C.14$211
Sumitomo Pharma America, Inc.7$195
Dexcom, Inc.6$191
Merck12$171
Takeda Pharmaceuticals U.S.A., Inc.9$168
Xeris Pharmaceuticals, Inc.8$155
Sunovion Pharmaceuticals Inc.8$137
Astellas Pharma US Inc8$136
Mylan Specialty L.p.7$132
Boston Scientific8$126
Lundbeck LLC6$116
Antares Pharma, Inc.7$114
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)5$112
Teva Pharmaceuticals USA, Inc.8$105
Bayer6$102
Medtronic(2 entities)5$102
Phathom Pharmaceuticals, Inc.4$83
Boehringer Ingelheim3$67
Axsome Therapeutics, Inc.3$65
Shire North American Group Inc4$60
Edwards Lifesciences3$58
Exact Sciences3$56
Nestle Healthcare Nutrition Inc.2$44
Philips North America LLC2$39
Gilead2$39
Regeneron Healthcare Solutions, Inc.2$39
Eisai Inc.3$38
Ironwood Pharmaceuticals, Inc2$38
Inspire Medical Systems, Inc.1$35
Shield Therapeutics Inc2$33
Inari Medical, Inc.1$32
Axonics, Inc.1$32
Strongbridge US Inc.2$28
Abiomed1$27
Intuity Medical Inc1$26
Verity Pharmaceuticals Inc.1$24
Urovant Sciences Inc1$24
Viatris Specialty LLC1$24
Jazz Pharmaceuticals Inc.1$23
Apria Healthcare LLC1$22
Idorsia Pharmaceuticals US Inc1$21
Verona Pharma, Inc.1$21
Neurocrine Biosciences, Inc.1$21
Bausch Health US, LLC1$21
Sanofi Pasteur Inc.1$21

How this compares

$9,804 in reported general payments places this provider in the 90th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$739,223
Medicare patients
1,342
Services billed
11,020

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide543$641,861
EliquisApixaban448$470,187
RybelsusSemaglutide140$197,945
MounjaroTirzepatide161$179,039
JardianceEmpagliflozin150$163,569
FarxigaDapagliflozin Propanediol159$146,210
XareltoRivaroxaban99$106,760
Trelegy ElliptaFluticasone/Umeclidin/Vilanter103$101,601
EntrestoSacubitril/Valsartan80$71,689
LinzessLinaclotide61$56,715
MyrbetriqMirabegron64$55,938
Breztri AerosphereBudesonide/Glycopyr/Formoterol68$51,812
TrulicityDulaglutide35$51,404
Bydureon BciseExenatide Microspheres47$35,897
JanuviaSitagliptin Phosphate39$35,223

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$587$839,806683 claims
PfizerEliquis$505$470,187448 claims
Lilly USA, LLCMounjaro, Trulicity$276$230,443196 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$604$205,924246 claims
Boehringer IngelheimJardiance$67$163,569150 claims
GSKTrelegy Ellipta, Anoro Ellipta$658$116,517119 claims
Johnson & JohnsonXarelto$251$106,76099 claims
AbbVieLinzess, Vraylar$1,026$76,75779 claims
NovartisEntresto$242$71,68980 claims
Astellas Pharma US IncMyrbetriq$136$55,93864 claims
MerckJanuvia, Dulera$171$44,00255 claims
Sumitomo Pharma America, Inc.Gemtesa$195$12,07722 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Summerville

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →